HA
IDXX icon

Harfst & Associates’s Idexx Laboratories IDXX Stock Holding History

Harfst & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-180
Closed -$29K – 137
2017
Q2 		$29K Hold
180
– – 0.01% 158
2017
Q1 		$27K Buy
+180
New +$24.8K 0.01% 169
2015
Q4 		– Sell
-26
Closed -$2K – 300
2015
Q3 		$2K Sell
26
-430
-94% -$30.8K ﹤0.01% 267
2015
Q2 		$29K Buy
+456
New +$31.6K 0.02% 209

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Harfst & Associates's IDXX Position: Q3 2017 in Review

Harfst & Associates sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 180 shares — an estimated $29K sold.

Harfst & Associates first reported a position in IDXX in Q2 2015 and held it in 4 quarters. The position peaked at $29K in Q2 2017. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Harfst & Associates reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • Harfst & Associates sold 180 Idexx Laboratories shares in Q3 2017, an estimated $29K.
  • Harfst & Associates first reported a position in Idexx Laboratories in Q2 2015 and held it in 4 quarters.
  • Harfst & Associates's Idexx Laboratories position peaked at $29K in Q2 2017.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Harfst & Associates's 13F filing for Q3 2017, filed 7 Nov 2017.